Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study
Schizophrenia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring schizophrenia
Eligibility Criteria
Inclusion Criteria: Male participants Between the ages of 18 and 50 Meet diagnostic criteria for schizophrenia or schizoaffective disorder Are clinically stable for a minimum of 3 months on current dose of medication Are unemployed (i.e., work less than 20 hours per week at competitive employment) Exclusion Criteria: Psychoactive substance dependence within the past 6 months or substance abuse within the past month History of head trauma or other neurological disorder Medical illness or medications, such as benzodiazepine treatment or HIV medications, that may be affected by study participation (the study doctor will discuss this with potential subjects) Mental retardation Seizure disorder History of a heart attack, arrhythmia, or other heart disease
Sites / Locations
- University of Pittsburgh
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Merck L-830982
Sugar pill